Keywords
Last Name
Institution

Pass Through Agency: Parexel
Funding Agency: Pfizer
Title: An Open-Label Extension study to evaluate the safety of Rivipansel in the treatment of one or more vaso-occlusive crises in hospitalized subjects with sickle cell disease
Start Date: 2017-05-01


Collapse Overview 
Collapse researcher role of